SCHEMBL5350394

SCHEMBL5350394

O=S(=O)(NCc1cccs1)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.73
POLB P06746 3/20 0.73
TDP1 Q9NUW8 1/20 0.73
HTT P42858 5/20 0.60
LMNA P02545 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
STAT3 P40763 1/20 0.60
TSHR P16473 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
GAA P10253 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
MMP2 P08253 3/20 0.52
ADAMTS4 O75173 2/20 0.52
MMP13 P45452 2/20 0.52
MMP14 P50281 2/20 0.52
ADAMTS5 Q9UNA0 2/20 0.52
MMP1 P03956 1/20 0.52
MEP1B Q16820 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1874186 0.87 ALDH1A1 (0.68) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL14484120 0.84 ALDH1A1 (0.66) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL28003774 0.80 ALDH1A1 (0.72) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL12793685 0.80 ALDH1A1 (0.72) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL11887767 0.80 KMT2A (0.68) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL28113726 0.80 ALDH1A1 (0.68) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL10288218 0.79 POLB (0.63) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL3562140 0.77 ALDH1A1 (0.64) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL8324532 0.77 ALDH1A1 (0.64) ALDH1A1POLBTDP1HTTLMNA
SCHEMBL13712056 0.77 ALDH1A1 (0.64) ALDH1A1POLBTDP1HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 ALDH1A1 378/4885POLB 1599/4885TDP1 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.